Causes of death among people who used illicit opioids in England, 2001–18: a matched cohort study

Dan Lewer*, Thomas D. Brothers, Naomi Van Hest, Matthew Hickman, Adam Holland, Prianka Padmanathan, Paola Zaninotto

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Background: In many countries, the average age of people who use illicit opioids, such as heroin, is increasing. This has been suggested to be a reason for increasing numbers of opioid-related deaths seen in surveillance data. We aimed to describe causes of death among people who use illicit opioids in England, how causes of death have changed over time, and how they change with age. Methods: In this matched cohort study, we studied patients in the Clinical Practice Research Datalink with recorded illicit opioid use (defined as aged 18–64 years, with prescriptions or clinical observations that indicate use of illicit opioids) in England between Jan 1, 2001, and Oct 30, 2018. We also included a comparison group, matched (1:3) for age, sex, and general practice with no records of illicit opioid use before cohort entry. Dates and causes of death were obtained from the UK Office for National Statistics. The cohort exit date was the earliest of date of death or Oct 30, 2018. We described rates of death and calculated cause-specific standardised mortality ratios. We used Poisson regression to estimate associations between age, calendar year, and cause-specific death. Findings: We collected data for 106 789 participants with a history of illicit opioid use, with a median follow-up of 8·7 years (IQR 4·3–13·5), and 320 367 matched controls with a median follow-up of 9·5 years (5·0–14·4). 13 209 (12·4%) of 106 789 participants in the exposed cohort had died, with a standardised mortality ratio of 7·72 (95% CI 7·47–7·97). The most common causes of death were drug poisoning (4375 [33·1%] of 13 209), liver disease (1272 [9·6%]), chronic obstructive pulmonary disease (COPD; 681 [5·2%]), and suicide (645 [4·9%]). Participants with a history of illicit opioid use had higher mortality rates than the comparison group for all causes of death analysed, with highest standardised mortality ratios being seen for viral hepatitis (103·5 [95% CI 61·7–242·6]), HIV (16·7 [9·5–34·9]), and COPD (14·8 [12·6–17·6]). In the exposed cohort, at age 20 years, the rate of fatal drug poisonings was 271 (95% CI 230–313) per 100 000 person-years, accounting for 59·9% of deaths at this age, whereas the mortality rate due to non-communicable diseases was 31 (16–45) per 100 000 person-years, accounting for 6·8% of deaths at this age. Deaths due to non-communicable diseases increased more rapidly with age (1155 [95% CI 880–1431] deaths per 100 000 person-years at age 50 years; accounting for 52·0% of deaths at this age) than did deaths due to drug poisoning (507 (95% CI 452–562) per 100 000 person-years at age 50 years; accounting for 22·8% of deaths at this age). Mirroring national surveillance data, the rate of fatal drug poisonings in the exposed cohort increased from 345 (95% CI 299–391) deaths per 100 000 person-years in 2010–12 to 534 (468–600) per 100 000 person-years in 2016–18; an increase of 55%, a trend that was not explained by ageing of participants. Interpretation: People who use illicit opioids have excess risk of death across all major causes of death we analysed. Our findings suggest that population ageing is unlikely to explain the increasing number of fatal drug poisonings seen in surveillance data, but is associated with many more deaths due to non-communicable diseases. Funding: National Institute for Health Research.

Original languageEnglish
Pages (from-to)e126-e135
JournalThe Lancet Public Health
Volume7
Issue number2
DOIs
Publication statusPublished - Feb 2022
Externally publishedYes

Bibliographical note

Funding Information:
Public Health England (now called The UK Health Security Agency; the Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division team at the National Infections Services) provided aggregated data showing the age structure of participants in the Unlinked Anonymous Monitoring Survey of Infections and Risk among People who Inject Drugs. This study was funded by the National Institute for Health Research (NIHR; grant awarded to DL: DRF-2018-11-ST2-016). The views expressed in this article are those of the authors and not necessarily those of the NIHR, or the Department of Health and Social Care. TDB is supported by the Dalhousie University Internal Medicine Research Foundation Fellowship, Canadian Institutes of Health Research Fellowship (CIHR-FRN# 171259), and Research in Addiction Medicine Scholars Program (National Institutes of Health, National Institute on Drug Abuse; R25DA033211). PP's PhD Clinical Fellowship is funded by the UK Medical Research Council Addiction Research Clinical Training programme (MR/N00616X/1).

Funding Information:
Public Health England (now called The UK Health Security Agency; the Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division team at the National Infections Services) provided aggregated data showing the age structure of participants in the Unlinked Anonymous Monitoring Survey of Infections and Risk among People who Inject Drugs. This study was funded by the National Institute for Health Research (NIHR; grant awarded to DL: DRF-2018-11-ST2-016). The views expressed in this article are those of the authors and not necessarily those of the NIHR, or the Department of Health and Social Care. TDB is supported by the Dalhousie University Internal Medicine Research Foundation Fellowship, Canadian Institutes of Health Research Fellowship (CIHR-FRN# 171259), and Research in Addiction Medicine Scholars Program (National Institutes of Health, National Institute on Drug Abuse; R25DA033211). PP's PhD Clinical Fellowship is funded by the UK Medical Research Council Addiction Research Clinical Training programme (MR/N00616X/1).

Publisher Copyright:
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4·0 license

Fingerprint

Dive into the research topics of 'Causes of death among people who used illicit opioids in England, 2001–18: a matched cohort study'. Together they form a unique fingerprint.

Cite this